Bridges Investment Management Inc. Grows Stock Holdings in Colgate-Palmolive (NYSE:CL)

Bridges Investment Management Inc. increased its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 11.3% in the 2nd quarter, HoldingsChannel reports. The firm owned 12,837 shares of the company’s stock after acquiring an additional 1,300 shares during the quarter. Bridges Investment Management Inc.’s holdings in Colgate-Palmolive were worth $1,246,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in CL. Gryphon Financial Partners LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $225,000. Cambridge Investment Research Advisors Inc. grew its stake in shares of Colgate-Palmolive by 6.1% during the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 184,902 shares of the company’s stock worth $14,739,000 after purchasing an additional 10,589 shares during the period. TCW Group Inc. purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at approximately $1,428,000. Team Hewins LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $374,000. Finally, Orion Portfolio Solutions LLC boosted its holdings in Colgate-Palmolive by 13.2% during the fourth quarter. Orion Portfolio Solutions LLC now owns 50,526 shares of the company’s stock worth $4,062,000 after buying an additional 5,888 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CL. Barclays lifted their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a report on Monday, July 29th. TD Cowen upped their price target on Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Tuesday, July 30th. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Stifel Nicolaus boosted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, July 22nd. Finally, Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $102.79.

Read Our Latest Stock Analysis on Colgate-Palmolive

Insider Buying and Selling

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now owns 13,942 shares in the company, valued at $1,439,929.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares of the company’s stock, valued at $1,069,868.70. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 43,490 shares of company stock worth $4,486,063. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 1.0 %

CL stock opened at $103.03 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90. The firm has a 50-day moving average of $102.71 and a two-hundred day moving average of $95.76. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $109.30. The company has a market cap of $84.53 billion, a price-to-earnings ratio of 32.60, a PEG ratio of 3.72 and a beta of 0.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. The firm had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.77 earnings per share. As a group, analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.94%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.